93 related articles for article (PubMed ID: 24275885)
1. Rhabdomyoblastic differentiation in metastatic melanoma: making sense of a rare but complex form of mimicry.
Reilly DJ; Volchek M; Ting JW; Allan P; Findlay MW
Int J Surg Pathol; 2014 Sep; 22(6):520-4. PubMed ID: 24275885
[TBL] [Abstract][Full Text] [Related]
2. Metastatic rhabdoid melanoma: report of a case with a comparative review of the literature.
Gavino AC; Gillies EM
J Cutan Pathol; 2008 Mar; 35(3):337-42. PubMed ID: 18251752
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical mismatch in a case of rhabdomyoblastic metastatic melanoma.
Dumitru AV; Tampa MŞ; Georgescu SR; Păunică S; Matei CN; Nica AE; Costache M; Motofei I; Sajin M; Păunică I; Georgescu TA
Rom J Morphol Embryol; 2018; 59(1):339-344. PubMed ID: 29940647
[TBL] [Abstract][Full Text] [Related]
4. Rhabdoid melanoma: A diagnostic ordeal.
Mehta A; Sharma A; Gupta G
Indian J Cancer; 2020; 57(4):473-477. PubMed ID: 33078756
[TBL] [Abstract][Full Text] [Related]
5. Primary Vaginal Melanoma With Rhabdoid Features: A Case Report and Literature Review.
Lee CK; Lin H; Su CF; Kok VC
Int J Gynecol Pathol; 2017 Sep; 36(5):499-504. PubMed ID: 28800579
[TBL] [Abstract][Full Text] [Related]
6. Primary rhabdoid melanoma with clonal recurrence.
Tallon B; Bhawan J
Am J Dermatopathol; 2009 Apr; 31(2):200-4. PubMed ID: 19318811
[TBL] [Abstract][Full Text] [Related]
7. Melanoma with rhabdomyosarcomatous differentiation: two further cases of a rare pathologic pitfall.
Shenjere P; Fisher C; Rajab R; Patnaik L; Hazell S; Thway K
Int J Surg Pathol; 2014 Sep; 22(6):512-9. PubMed ID: 24788528
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyoblastic differentiation in malignant melanoma in adults: report of 2 cases.
Gharpuray-Pandit D; Coyne J; Eyden B; Banerjee SS
Int J Surg Pathol; 2007 Jan; 15(1):20-5. PubMed ID: 17172493
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous extrarenal rhabdoid tumor with myogenic differentiation.
Petitt M; Doeden K; Harris A; Bocklage T
J Cutan Pathol; 2005 Nov; 32(10):690-5. PubMed ID: 16293182
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnostics in melanoma.
Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical diagnostic and prognostic markers for melanoma.
Nosrati M; Kashani-Sabet M
Methods Mol Biol; 2014; 1102():259-73. PubMed ID: 24258983
[TBL] [Abstract][Full Text] [Related]
12. Rhabdoid tumor mimicking hemangioma.
Assen YJ; Madern GC; de Laat PC; den Hollander JC; Oranje AP
Pediatr Dermatol; 2011; 28(3):295-8. PubMed ID: 20825569
[TBL] [Abstract][Full Text] [Related]
13. Update of diagnostic and prognostic markers in cutaneous malignant melanoma.
Reed JA; Albino AP
Clin Lab Med; 2000 Dec; 20(4):817-38. PubMed ID: 11221516
[TBL] [Abstract][Full Text] [Related]
14. The impact of molecular morphology techniques on the expert diagnosis in melanocytic skin neoplasms.
Ferrara G; Misciali C; Brenn T; Cerroni L; Kazakov DW; Perasole A; Russo R; Ricci R; Crisman G; Fanti PA; Passarini B; Patrizi A
Int J Surg Pathol; 2013 Oct; 21(5):483-92. PubMed ID: 23775023
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum.
Plaza JA; Torres-Cabala C; Evans H; Diwan HA; Suster S; Prieto VG
Am J Dermatopathol; 2010 Apr; 32(2):129-36. PubMed ID: 20010406
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
[TBL] [Abstract][Full Text] [Related]
18. KBA.62: a useful marker for primary and metastatic melanomas.
Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
[TBL] [Abstract][Full Text] [Related]
19. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
20. [Immuno-diagnosis of malignant melanoma].
Szekeres G; Battyáni Z
Magy Onkol; 2003; 47(1):45-50. PubMed ID: 12704454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
